Navigation Links
3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
Date:6/2/2008

Study finds treatment well-tolerated, kept tumors stable for almost 6 months

MONDAY, June 2 (HealthDay News) -- A combination therapy of gemcitabine, capecitabine and bevacizumab improves outcomes in patients with advanced pancreatic cancer, according to a multi-center study led by researchers at Roswell Park Cancer Institute in Buffalo, N.Y.

The study of 50 patients found that this combination treatment was well-tolerated by patients, was able to prevent tumors from progressing for almost six months, and improved median survival to 9.8 months.

The study was expected to be presented Monday at the American Society of Clinical Oncology annual meeting, in Chicago.

Patients with advanced pancreatic cancer -- one of the most deadly types of solid tumors -- have a median survival of six months after diagnosis. About 37,680 people in the United States will be diagnosed with pancreatic cancer in 2008.

While gemcitabine and capecitabine have improved quality of life for patients with advanced pancreatic cancer, they haven't led to a significant improvement in survival time, according to background information in the study.

Bevacizumab, which reduces blood supply to tumor, has improved outcomes when added to chemotherapy for patients with colon, lung and breast cancers.

More information

The National Cancer Institute has more about pancreatic cancer.



-- Robert Preidt



SOURCE: Roswell Park Cancer Institute, news release, June 2, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. 3-drug combination extremely promising as first-line therapy for multiple myeloma
2. Radiation and drug combo helps boost efficacy of lung cancer treatment
3. Aerobic, Weight Training Combo Best Against Diabetes
4. New antibiotic drug combo to speed up treatment of tuberculosis
5. Drug Combo Helps Fight Marfan Syndrome
6. Drug Combo Blocks Pain Without Impairing Movement
7. Two-Drug Combo Fights Brain Tumors
8. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
9. Drug Combo Boosts Multiple Myeloma Survival
10. Drug Combos Effective Against Rheumatoid Arthritis
11. Combo PET/CT Scan Helps Spot Breast Cancers Spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves clients ... (FEMA) recent update of flood zones, more people than ever are in flood ... to reflect the actual risk in flood zone areas during a time when ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... management, financial planning, and related services to families and business owners in and ... charity drive to benefit senior citizens in the area. , Meals on Wheels ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a ... and business owners in North Central West Virginia, is embarking on a cooperative ... abled residents in the region. , The Stepping Stones organization offers a series ...
(Date:6/22/2017)... ... June 22, 2017 , ... Plastic Surgery Associates is proud to ... for 2017. Each year, research and information firm, Castle Connolly, releases their list of ... 2015, this marks the 3rd time that Dr. Canales has been recognized ...
(Date:6/22/2017)... ... June 22, 2017 , ... Children’s National Health ... Association (AHA) to launch a Rheumatic Heart Disease Center, with the goal of ... rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
(Date:6/8/2017)... 8, 2017  StatLab Medical Products ("StatLab" ... manufacturer of diagnostic supplies for the anatomic ... & Company LP ("Cressey & Company"), a ... growth-focused investment in the Company. Cressey & ... from selling shareholder, Prairie Capital, L.P., with ...
(Date:6/5/2017)... , June 5, 2017 The Cincinnati ... of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded a ... Enquirer . Results are based on an employee ... organizational health and workplace improvement. The survey measures several aspects ... ...
Breaking Medicine Technology: